Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma

Sally F. Barrington; Wendi Qian; Edward J. Somer; Antonella Franceschetto; Bruno Bagni; Eva Brun; Helen Almquist; Annika Loft; Liselotte Hojgaard; Massimo Federico; Andrea Gallamini; Paul Smith; Peter Johnson; John Radford; Michael O'Doherty

doi:10.1007/s00259-010-1490-5

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma

Sally F. Barrington, Wendi Qian, Edward J. Somer, Antonella Franceschetto, Bruno Bagni, Eva Brun, Helen Almquist, Annika Loft, Liselotte Hojgaard, Massimo Federico, Andrea Gallamini, Paul Smith, Peter Johnson, John Radford, Michael O'Doherty

PET Imaging Centre Facility

Research output: Contribution to journal › Article › peer-review

300 Citations (Scopus)

Abstract

To determine if PET reporting criteria for the Response Adapted Treatment in Hodgkin Lymphoma (RATHL) trial could enable satisfactory agreement to be reached between 'core' laboratories operating in different countries.

Original language	English
Pages (from-to)	1824 - 1833
Number of pages	10
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	37
Issue number	10
DOIs	https://doi.org/10.1007/s00259-010-1490-5
Publication status	Published - Oct 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00259-010-1490-5

Cite this

Barrington, S. F., Qian, W., Somer, E. J., Franceschetto, A., Bagni, B., Brun, E., Almquist, H., Loft, A., Hojgaard, L., Federico, M., Gallamini, A., Smith, P., Johnson, P., Radford, J., & O'Doherty, M. (2010). Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 37(10), 1824 - 1833. https://doi.org/10.1007/s00259-010-1490-5

@article{3d0259f94fe949d7923d95311a94b468,

title = "Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma",

abstract = "To determine if PET reporting criteria for the Response Adapted Treatment in Hodgkin Lymphoma (RATHL) trial could enable satisfactory agreement to be reached between 'core' laboratories operating in different countries.",

author = "Barrington, {Sally F.} and Wendi Qian and Somer, {Edward J.} and Antonella Franceschetto and Bruno Bagni and Eva Brun and Helen Almquist and Annika Loft and Liselotte Hojgaard and Massimo Federico and Andrea Gallamini and Paul Smith and Peter Johnson and John Radford and Michael O'Doherty",

year = "2010",

month = oct,

doi = "10.1007/s00259-010-1490-5",

language = "English",

volume = "37",

pages = "1824 -- 1833",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7089",

publisher = "SPRINGER",

number = "10",

}

Barrington, SF, Qian, W, Somer, EJ, Franceschetto, A, Bagni, B, Brun, E, Almquist, H, Loft, A, Hojgaard, L, Federico, M, Gallamini, A, Smith, P, Johnson, P, Radford, J & O'Doherty, M 2010, 'Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma', European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 10, pp. 1824 - 1833. https://doi.org/10.1007/s00259-010-1490-5

TY - JOUR

T1 - Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma

AU - Barrington, Sally F.

AU - Qian, Wendi

AU - Somer, Edward J.

AU - Franceschetto, Antonella

AU - Bagni, Bruno

AU - Brun, Eva

AU - Almquist, Helen

AU - Loft, Annika

AU - Hojgaard, Liselotte

AU - Federico, Massimo

AU - Gallamini, Andrea

AU - Smith, Paul

AU - Johnson, Peter

AU - Radford, John

AU - O'Doherty, Michael

PY - 2010/10

Y1 - 2010/10

N2 - To determine if PET reporting criteria for the Response Adapted Treatment in Hodgkin Lymphoma (RATHL) trial could enable satisfactory agreement to be reached between 'core' laboratories operating in different countries.

AB - To determine if PET reporting criteria for the Response Adapted Treatment in Hodgkin Lymphoma (RATHL) trial could enable satisfactory agreement to be reached between 'core' laboratories operating in different countries.

U2 - 10.1007/s00259-010-1490-5

DO - 10.1007/s00259-010-1490-5

M3 - Article

C2 - 20505930

SN - 1619-7089

VL - 37

SP - 1824

EP - 1833

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 10

ER -

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this